Bank of Montreal’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-63
Closed 5040
2018
Q4
$0 Sell
63
-11
-15% -$7 ﹤0.01% 4974
2018
Q3
$0 Sell
74
-2
-3% -$7 ﹤0.01% 4990
2018
Q2
$0 Sell
76
-3,050
-98% -$13.8K ﹤0.01% 4955
2018
Q1
$18K Buy
3,126
+25
+0.8% +$181 ﹤0.01% 3592
2017
Q4
$25K Sell
3,101
-14,715
-83% -$134K ﹤0.01% 3522
2017
Q3
$176K Sell
17,816
-9,170
-34% -$131K ﹤0.01% 2718
2017
Q2
$564K Buy
26,986
+16,290
+152% +$341K ﹤0.01% 2217
2017
Q1
$268K Buy
10,696
+10,630
+16,106% +$274K ﹤0.01% 2334
2016
Q4
$2K Buy
66
+40
+154% +$1.12K ﹤0.01% 3923
2016
Q3
$1K Hold
26
﹤0.01% 3974
2016
Q2
$0 Hold
26
﹤0.01% 4447
2016
Q1
$1K Hold
26
﹤0.01% 4133
2015
Q4
$1K Sell
26
-3
-10% -$58 ﹤0.01% 4152
2015
Q3
$1K Hold
29
﹤0.01% 3924
2015
Q2
$1K Hold
29
﹤0.01% 3877
2015
Q1
$1K Hold
29
﹤0.01% 3899
2014
Q4
$1K Sell
29
-1
-3% -$27 ﹤0.01% 3955
2014
Q3
$1K Buy
30
+1
+3% +$29 ﹤0.01% 3973
2014
Q2
$1K Hold
29
﹤0.01% 4605
2014
Q1
$1K Hold
29
﹤0.01% 3969
2013
Q4
$1K Hold
29
﹤0.01% 3685
2013
Q3
$1K Buy
29
+28
+2,800% +$550 ﹤0.01% 3747
2013
Q2
$0 Buy
+1
New +$18 ﹤0.01% 3679

Bank of Montreal's IPCI Position: Q1 2019 in Review

Bank of Montreal sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 63 shares.

Bank of Montreal first reported a position in IPCI in Q2 2013 and held it in 23 quarters. The position peaked at $564K in Q2 2017. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.

  • Bank of Montreal reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
  • Bank of Montreal sold 63 Intellipharmaceuticals International Inc. shares in Q1 2019.
  • Bank of Montreal first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 23 quarters.
  • Bank of Montreal's Intellipharmaceuticals International Inc. position peaked at $564K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.

Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.